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Abstract 
  
Parkinson disease (PD) is a neurodegenerative movement disorder that affects 1 to 2% of 
the human population over the age of 65. This prevalent disease has characteristics including 
resting tremor, rigidity, bradykinesia and postural instability due to the loss of dopaminergic 
neurons in the substantia nigra pars compacta in the brain. Mitochondrial dynamics play a 
significant role in PD with a balance between surveillance and biogenesis being key. The newly 
discovered gene Paris has been proposed to be central in the coordination of mitochondrial 
processes. These processes seem to be controlled by a number of PD associated genes. We have 
identified CG15436 as an excellent candidate to carry out studies on the Paris function in 
Drosophila melanogaster. Knockdown of CG15436 reduces longevity and locomotor ability 
overtime to produce a Paris dependent Drosophila model of PD. As well, CG15436 RNA 
interference negatively influences neurodevelopment when expressed in the eye. Interestingly, 
overexpression of CG15436 produces similar results to knockdown of CG15436 in longevity and 
locomotor assays as well as eye phenotypic expression. Alterations to the expression of the Paris 
candidate, either through ectopic expression or knockdown seem to result in a suboptimal set of 
conditions that lead to potential models of PD. As such, CG15436 seems to fulfill the conditions 
to indicate that it functions as Paris in the Drosophila model system. 
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Introduction 
 
Purpose 
 Parkinson disease (PD) is a neurodegenerative disease that has a significant influence 
upon our society today. Although common, and despite the fact that the symptoms of this 
debilitating disease are generally not present until later in life, the consequences of this disease 
are great and are observed all around the world. The aim of this study is to characterize the gene 
Paris and determine its influence upon the control of locomotor and survivorship abilities and 
therefore its relationship with PD through a Drosophila melanogaster model. The relationship 
between mitochondrial function and the effect that Parkinson disease has on these important 
organelles will be of importance in this study.  
 
Parkinson Disease 
Parkinson disease (PD) is a neurodegenerative movement disorder that affects 1 to 2% of 
the human population over the age of 65. This makes this disease one of the most prevalent in 
our world today (Weintraub et al., 2008). PD is the second most common neurodegenerative 
disorder, with Alzheimer disease being the most common (de Lau and Breteler, 2006). A 
pathological sign of PD is the loss of dopaminergic neurons in the substantia nigra pars 
compacta in the brain of the patient (Zhou et al., 2017). PD has characteristics including resting 
tremor, rigidity, bradykinesia and postural instability. As life expectancy increases, so too does 
the prevalence of PD with 4 to 5% of the population over the age of 85 affected (Trinh et al., 
2014). Patients with PD have a progression of neuronal degeneration and Lewy bodies 
(numerous protein aggregations) present in the cerebral cortex and limbic structures. This may 
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eventually lead to dementia in 25 to 40% of PD patients (de Lau and Breteler, 2006). As 
explained, this progressive neurodegenerative disease leads to many detrimental characteristics. 
Genetic mutations explain only a small portion of the cases of PD since approximately 
90% of PD cases are sporadic (de Lau and Breteler, 2006).  It is important to understand the 
mechanisms involved in PD and this came with the identification of the forms of PD that are 
inherited, which are not distinguishable from the sporadic forms (Schielsing et al., 2008). These  
rare familial forms account for approximately 15% of PD cases, and clinical, pathological and 
biochemical features are common between sporadic and familial forms of PD which allows for 
insight into the genes involved in PD (Ammal Kaidery and Thomas, 2018). There is no cure for 
this progressive neurodegenerative disease. There have been some treatments developed 
although all only providing temporary relief from the symptoms. 
 
Mitochondria and Parkinson disease 
 Mitochondria are vital organelles in cells of eukaryotic organisms that are needed to 
maintain homeostasis (Bingol and Sheng, 2016; Franz et al., 2015). These double membrane-
bound organelles are very important in the metabolism of the cell and are necessary for cellular 
survival (Baker et al., 2013). The number and dynamic morphology of mitochondria in the cell 
are balanced with the regulation of biogenesis and mitophagy (mitochondrial autophagy) during 
the ageing of the organism as well as its conditional stress response (Franz et al., 2015). There 
are many different cellular pathways that help to keep mitochondria functional and healthy 
(Bingol and Sheng, 2016). Cell signalling pathways are an important role of mitochondria (Franz 
et al., 2015). Since mitochondria provide a large portion of the energy that is needed for proper 
cellular function, its decline plays a key role in ageing (Weinrich et al., 2017). Mitochondria 
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have internal mechanisms, which are used to refold or degrade proteins that are rendered non-
functional or damaged (Franz et al., 2015). Mitophagy is important in metabolism as it adjusts 
the mass of mitochondria and removes mitochondria during certain processes of differentiation. 
Autophagy as well as the ubiquitin-proteasome system support mitochondrial surveillance. The 
failure of the process of mitochondrial surveillance and autophagy is linked to PD. (Franz et al., 
2015). When whole mitochondrial segments are damaged, selective removal of these 
mitochondria occurs due to mitophagy (Baker et al., 2013).  
A functional decline in mitochondrial autophagy of dopaminergic neurons is a 
characteristic of PD and these neurons present in the substantia nigra are under a much higher 
mitochondrial stress. Due to this higher stress, they are much more vulnerable to defects that can 
occur due to genetic mutations related to Parkinson disease (Bingol and Sheng, 2016). Gene 
mutations in genes such as PINK1 and Parkin are related to PD through involvement with 
mitochondrial maintenance and turnover (Wang et al., 2016). Parkin-mediated proteasomal 
turnover of mitofusin (outer membrane GTPases of the mitochondria) is vital to the fission-
driven separation of parts of the mitochondria that get damaged, which can lead to selective 
ubiquitination of non-functional mitochondria (Franz et al., 2015). Neurological diseases can be 
the result of mitochondrial dysfunction at any level in the hierarchy of quality control. This 
mitochondrial dysfunction is related to a large quantity of diseases due to the importance of 
mitochondrial function in cell survival (Baker et al., 2013). It is important to understand the 
connection between mitochondria and PD for further research into the disease. 
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Drosophila melanogaster as a model organism 
  There are only two and a half times more genes present in the human genome than in 
that of the fly, with most of the additional genes being duplicates. This animal is such a good 
model organism mainly due to its ease of use. The animal is very easy to maintain in a laboratory 
setting and its breeding is non-problematic. The generation time for this animal is very short at 
just two weeks, which makes it very important and useful in genetic studies (Burdette and van 
den Heuvel, 2004). Much is known about the Drosophila melanogaster genome and there is a D. 
melanogaster homologue for 75% of human disease genes (Marsh et al., 2003). Due to the ease 
of genetic manipulation as well as all of these aspects mentioned, D. melanogaster is an ideal 
model organism for human diseases (Brand and Perrimon, 1993). This makes this organism an 
ideal organism for my study on PD. 
 Neurodegenerative disease can be modeled in D. melanogaster. The nervous system in 
Drosophila is similar to that of humans. The similarities stretch across the components of the 
nervous system such as the brain, neurons and the glia (O’Kane, 2011). The nervous system of 
an adult D. melanogaster has 105 neurons. The nervous system has a bilaterally symmetrical 
brain which is connected to a ventral nerve cord. This nerve cord then innervates the thorax and 
abdomen. The brain of D. melanogaster is made up of three lobes which are called the 
protocerebrum, deutocerebrum and the tritocerebrum. These three lobes have been shown to be 
homologous to the forebrain, midbrain and hindbrain regions of vertebrates. The human nervous 
system contains 4 lobes and approximately 100 billion neurons which makes it a much more 
complex nervous system than that of D. melanogaster (Herculano-Houzel, 2012). Although there 
is a difference in the complexities of the human and D. melanogaster nervous systems, the 
nervous systems have similarities in their shape, biochemical properties and their synaptic 
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functions (Lee et al., 2010). There are many of similarities between human and D. melanogaster 
neurons in both functional and molecular characteristics. These characteristics include axons, 
pumps, dentrites, voltage-gated channels, presynaptic vesicles and the manner of synaptic vesicle 
release (O’Kane, 2011). Due to these similarities between the human and D.  melanogaster 
nervous system, Drosophila are an excellent model organism for the study of neurodegeneration.    
Neurodevelopmental defects can be analysed in the Drosophila eye. The eye of D. 
melanogaster is made up of a repetitive pattern of ommatidia (Figure 1). Neurodevelopment can 
be measured using the eye structure due to its association with neurons. Neuron specific 
expression can be achieved in the eye cells using a driver, GMR-GAL4 (Marsh et al., 2003). The 
differentiation of the specialized cells that will become photoreceptors starts in the eye imaginal 
disc with clusters of differentiating neurons. The eye is formed as the morphogenetic furrow 
moves from posterior to anterior. The fully formed adult eye of D. melanogaster has 750 to 800 
ommatidia which are used for light sensing (Frankfort and Mardon, 2002). Each ommatidium is 
comprised of 20 cells, which include the photoreceptor neurons, pigment cells, cone cells and 
bristles (Sarkar et al., 2018). In each ommatidium, eight photoreceptors are present which are 
photosensitive neurons. This gives a total of over 6000 neurons in the eye of D. melanogaster 
(Frankfort and Mardon, 2002). The bristles, ommatidia and eye surface area can be analyzed, as 
changes in the structure of the eye can be an indicator of defects in neurodevelopment.   
  
UAS-GAL4 System 
There are many different types of genetic manipulation tools to use when conducting D. 
melanogaster genetic experiments. D. melanogaster can be used in forward genetic screens as an 
unbiased method, and used for the discovery of proteins and biochemical pathways. Forward 
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genetic screens are used to isolate mutants that affect genes of interest in research. Reverse 
genetic screens can be used and this tool required the knowledge of preexisting genetic 
information (Celotto and Palladino, 2005). Ectopic expression of a gene can be induced to 
overexpress or inhibit certain genes in transgenic organisms using the UAS-GAL4 system 
(Brand and Perrimon, 1993). This system uses a promoter to drive the expression of a 
transcriptional activator GAL4 which has been derived from yeast, Saccharomyces cerevisae, in 
order to activate a target gene.  The GAL4 protein acts as a transcriptional activator for only 
genes that have the GAL4 binding sites. It binds to the upstream activation sequence (UAS) and 
drives the gene expression (Figure 2). It is possible to control the gene expression very precisely 
with this method since GAL4 gets inserted near the gene of interest and UAS is further upstream 
in opposing parental lines (Phelps and Brand, 1998). The UAS-GAL4 system is an ideal system 
to use for genetic manipulation of genes for human disease research. 
 
RNA Interference (RNAi) and its Function 
 Over the last few years, an inducible RNA interference (RNAi) system has been 
developed. This system can be coupled with the UAS-GAL4 system in Drosophila (Dietzl et al., 
2007). The “knock down” effects of transcriptional genes can be studied with the use of this 
system. RNAi is a regulatory method to silence genes post-transcriptionally. RNAi recruits a 
naturally occurring RNA-degrading mechanism which destroys the activity of a selected 
endogenous gene. This is done without altering the selected endogenous gene. A ribonuclease III 
enzyme called Dicer splits the double stranded DNA into pieces of 21 to 23 lengths. These 
pieces then unwind into single stranded short interfering DNA. The single stranded short 
interfering RNA is then incorporated into the RNA-induced silencing complex (RISC). This 
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RISC complex is a riboprotein complex. RISC has a nuclease component called either Argonaute 
or Slicer which degrades the mRNA depending upon the exact complementarity of the short 
interfering RNA. The RISC component is able to travel through the cytoplasm and will only 
break up the particular RNA with which it compliments. Due to the degradation of the mRNA 
generated from a gene, the expression of that gene is silenced. The function of that gene is 
therefore lost and the effects of loss-of-function can be studied. With the function of a gene 
being lost, its effect in certain biological pathways can be observed as well as its role in these 
pathways.  
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Figure 1. Scanning electron micrograph of Drosophila melanogaster eye of the genotype 
GMR-GAL4; UAS-lacZ. The presence of ommatidia and bristles are evident in this image taken 
with the FEI MLA 650F scanning electron microscope (500x magnification).  
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Figure 2. UAS-GAL4 system in Drosophila melanogaster. 
 In this system, the maternal UAS line is crossed to the paternal GAL4 line in order to produce 
progeny with target genes expressed through the binding of UAS to GAL4. Redrawn using 
Microsoft Powerpoint 365 adapted from Brand and Perrimon (1993). 
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Gene of interest 
  Paris is known as the “parkin interacting substrate” as well as the “zinc finger protein 
746 (ZN746)”. Paris has been shown in previous studies to be required for the loss of 
dopaminergic neurons in adult conditional parkin knockout mice (Stevens et al., 2015). Paris has 
been shown to be involved in a pathway including parkin and PGC-1α (known as spargel in 
studies involving Drosophila melanogaster). Parkin and PGC-1α  have been shown to be 
associated with PD by their mutation or inactivation. Previous studies completed on Paris make 
this gene of great interest in PD research. 
Parkin is an ubiquitin E3 ligase encoded by the PARK2 gene (Siddiqui et al., 2016). Paris 
undergoes polyubiquitination by parkin which targets it though lysine-48 for ubiquitin 
proteasomal degradation (Stevens et al., 2015). This ability of parkin to regulate Paris is done 
through the ubiquitin proteasome system (Shin et al., 2011). Parkin is associated with autosomal 
recessive Parkinsonism as well as having a very important role in the quality control of 
mitochondria. This quality control is done through PINK1/parkin signalling (Zhou et al. 2017). A 
mutation in parkin has effects such as function loss which is linked to autosomal recessive PD 
(Stevens et al., 2015). Parkin has a role in increasing the PINK1 generated phosphoubiquitin 
signal. This role subsequently induces fast and stable mitophagy (Zhou et al., 2017). A loss of 
parkin leads to an increase in the size of mitochondria (Stevens et al., 2015). This gene is 
important to study due to its involvement with Paris and mitochondria.  
PGC-1α is involved in mitochondrial function and it is known that mitochondrial defects 
are a characteristic of Parkinson disease (Stevens et al., 2015). PGC-1α is a co-activating 
transcription factor that controls the transcription of many genes involved in cellular metabolism, 
as well as mitochondrial biogenesis and respiration (Shin et al., 2011). As such, it is a major 
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regulator of mitochondrial size, number and function. PGC-1α is a transcriptional regulator of 
numerous bioenergetic and antioxidant pathways. Based on other PD literature, studies have 
focused on defects in oxidative phosphorylation and the importance of energy production in 
neurons by PGC-1α (Stevens et al., 2015). The interaction between Paris, PGC-1α and parkin 
needs further research to understand their role.  
Paris is a transcriptional repressor and is involved in the expression regulation of PGC-1α 
(Stevens et al., 2015). It has been shown that a decrease in parkin is related to a subsequent 
increase in the Paris levels and then a reduction in the expression of PGC-1α (Siddiqui et al, 
2016). The identification of the new parkin interacting substrate may provide insight into the 
molecular mechanisms that are involved in neurodegeneration because of the relation to the 
inactivation of parkin in PD (Shin et al., 2011). A major driver in the degeneration of 
dopaminergic neurons and the defects in mitochondrial biogenesis is the Paris-mediated 
downregulation of PGC-1α that is due to the absence of parkin. The repression of the PGC-1α 
promotor due to the accumulation of Paris is a likely hindrance to mitochondrial protein 
production. This can lead to a decrease in the total number of mitochondria found in cells. The 
loss of parkin’s ubiquitin E3 ligase activity is the major cause for the loss of dopaminergic 
neurons. The increased Paris levels in PD, which are a result of the inactivation of parkin, are 
likely contributing to the pathogenesis of the neurodegenerative disease. This contribution is 
through the down-regulation of PGC-1α and some other target genes (Stevens et al., 2015). It is 
necessary to investigate these genes and their interactions to further understand their functions 
and association with PD.  
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Goals and Objectives 
 This aim of this study is to answer important questions in the field of neurobiological 
research using a variety of techniques. The effects of gene alteration examined in the model 
organism, D. melanogaster should provide insight into the following questions: Can the 
alteration of gene expression, overexpression or knockdown, of Paris provide a model for PD? 
What is the characterization, in terms of function, of the gene Paris and its link to PD? If one, 
what is the relationship among genes parkin, Paris and spargel and how do they interact and 
affect each other in their known pathway?  
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Materials and Methods 
Bioinformatics Analysis 
Identification of the Drosophila homologue of Paris from human sequence 
 The Drosophila melanogaster homologue of Paris was identified using the National 
Centre for Biotechnology Information’s (NCBI) tBLASTn search tool. The D. melanogaster 
genomic sequences were searched using the amino acid sequence of the human zinc finger 
protein 746 (accession number XP_005250012.1). Accession numbers were retrieved from 
NCBI to be used in the alignment. The closest Drosophila homologue was identified as 
CG15436 (accession number NM_134996.4) with 32% identical residues in the tBLASTn 
search. 
 
Identification of additional homologues, multiple alignment and domain identification 
 Homologues of Drosophila melanogaster Paris were identified using the NCBI’s Basic 
Local Alignment Search Tool (BLAST) with the tBLASTn function. The D. melanogaster 
CG15436 sequence was queried against the BLAST database. Sequences were aligned using 
Clustal Omega to show similarity. Domains were identified using Pfam (Sanger Institute) and 
NCBI Conserved Domains Database. A phylogenetic tree was constructed using Clustal Omega. 
The accession numbers for the alignment including vertebrates and invertebrates include 
Drosophila melanogaster CG15436 (accession number NM_134996.4), Culex quinquefasciatus 
zinc finger protein (accession number XM_001866910.1), Homo sapiens zinc finger protein 746 
(accession number XP_005250012.1) and Mus musculus zinc finger protein 746 (accession 
number XM_006506557.3). 
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 Two additional alignments were constructed. The vertebrate alignment included Homo 
sapiens zinc finger protein 746 (accession number XP_005250012.1), Mus musculus zinc finger 
protein 746 (accession number XM_006506557.3), Danio rerio zinc finger protein 
(XM_017355354.1) and Gallus gallus zinc finger protein 398-like (accession number 
XM_015281107.1). The invertebrate alignment included Drosophila melanogaster CG15436 
(accession number NM_134996.4), Copidosoma floridanum zinc finger protein 501-like 
(accession number XM_023390610.1), Culex quinquefasciatus zinc finger protein (accession 
number ZM_001846764.1) and Bombus impatiens zinc finger protein 271 (XM_012387283.2). 
 
Drosophila Culturing and Crosses 
Drosophila media 
Drosophila melanogaster stocks were maintained on a standard media composed of 65 
g/L cornmeal, 15 g/L yeast, 5.5 g/L agar and 50 ml/L fancy grade molasses in water with 5 ml of 
0.1 g/ml methyl paraben in ethanol and 2.5 ml of propionic acid. Approximately 7 ml of medium 
was allowed to solidify per vial. The medium was prepared by Dr. Brian E. Staveley 
approximately twice a month and stored at 4 to 6°C until use.  
 
Drosophila stocks 
All Drosophila stocks were obtained from the Bloomington Drosophila Stock Centre 
(Indiana University, IN, USA) unless otherwise noted. The overexpression line of CG15436 was 
obtained from FlyORF (University of Zurich, Switzerland). This line was not obtained until all 
crosses with knockdown lines of CG15436 were completed. These experiments were therefore 
completed at a later date as a separate set of experiments. The recombinant lines GMR-
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GAL4;UAS-parkRNAi and ddc-GAL4-UAS;parkRNAi were prepared by Dr. Brian E. Staveley. See 
Table 1 for a full list of all genotypes used.   
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Table 1: Genotypes of all stocks used to characterize CG15436 in this study 
 
Genotype Abbreviation Expression 
Pattern 
Balancer Reference 
Control Lines     
w; UAS-lacZ4-1-2 UAS-lacZ --- --- (Brand et 
al., 1994) 
Driver Lines     
w;GMR-GAL412 GMR-GAL4 Eye --- (Freeman, 
1996) 
w1118; P{Ddc-GAL4.L}4.3D 
 
ddc-GAL4 Neuron  (Li et al., 
2000) 
w*; P{ple-GAL4.F}3 
 
TH-GAL4 Dopaminergic 
neuron 
 (Inamdar et 
al., 2014) 
w[*]; 
P{w[+mW.hs]=GawB}D42 
 
D42-GAL4 Motorneuron-
specific 
 (Parkes et 
al., 1998) 
UAS Lines     
y1 sc* v1; P{TRiP.HMC04637}attP40 
 
UAS-
CG15436RNAi 
--- --- (Merzetti 
and 
Staveley, 
2016) 
y1; P{SUPor-
P}srlKG08646ry506/TM3, Sb1 Ser1 
 
UAS-
spargelRNAi 
--- 
 
--- (Benedyk et 
al., 1994) 
M{UAS-
CG15436.ORF.3xHA.GW}ZH-
86Fb 
 
UAS-
CG15436ORF 
--- --- (Staveley, 
unpublished) 
Recombinant Lines     
w; ddc-GAL4/CyO; UAS-
parkinRNAi/TM3 
GMR-GAL4; 
UAS-parkRNAi 
Eye  Staveley, 
unpublished 
w; GMR-GAL412/CyO; UAS-
parkinRNAi/TM3 
ddc-GAL4; 
UAS-parkRNAi  
Neuron  Staveley, 
unpublished 
 
 
 
 
 
 
 
	 17	
Drosophila crosses 
The stocks were stored at room temperature (~ 21°C). For crosses, males and females of 
desired phenotypes that contain UAS or GAL4 were mated. For the maternal genotype, virgin 
females were isolated every 8 to 12 hours. They were then mated with males of the appropriate 
genotype that had been isolated for 24 hours. For this mating, 3 to 5 females and 2 to 3 males of 
the chosen genotypes were placed on fresh media for breeding. In order to increase the 
productivity of the breeding, the flies were flipped onto new media 3 separate times every 2 to 3 
days. The parental flies were then discarded and the male progeny of the critical class were 
collected once eclosure occured. In order to drive gene expression, neuronal transgenes were 
used. An example of these neuronal transgenes is ddc-Gal4 (Li et al, 2000). The target genes 
were either knocked down by RNAi or overexpressed. The critical class males are those that do 
not express dominant mutant phenotypes associated with balancer chromosomes. Examples of 
these balancer chromosome phenotypes include Curly wings (CyO), Stubble bristles (TM3), or 
Tubby body and Humeral bristles (TM6B).   
 
 Biometric Analysis of the Compound Eye 
Eye analysis of D. melanogaster was used to determine the effects of gene manipulation 
on ommatidia and bristle numbers. Critical class males were collected by setting up crosses as 
previously described. The critical class male progeny which result from the individual crosses 
were collected when eclosure occurs and were matured for 3 to 5 days in groups of no more than 
20 on standard Drosophila medium at 25°C. They were then frozen and stored at a temperature 
of -80°C until use. These flies were thawed when ready to be mounted onto metal stubs onto 
their right side (left eye facing upwards) using forceps so that all eyes photographed were the left 
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eye. The sample size used for each cross made was ten flies. These stubs mounted with flies 
were desiccated for at least 24 hours before imaging. Scanning electron micrographs were taken 
of each male fly’s left eye using the Mineral Liberation Analyzer FEI 650F or the FEI Quanta 
400 Scanning Electron Microscope. The images were analyzed using the software program 
ImageJ (Abramoff et al., 2004). Total number of ommatidia and total number of bristles were 
determined. Data was analyzed using Graphpad Prism 7 (Graphpad Software Inc.) where mean ± 
standard error of the mean was calculated. Unpaired t-tests were used to determine significance. 
Results were deemed statistically significant when p < 0.05. 
 
Behavioural Assays 
Longevity assay 
An analysis of survival of Drosophila melanogaster was completed to examine the 
lifespan of affected flies and the comparison to control flies. Male progeny of the critical class 
were collected from crosses as described. The males were collected daily and placed in vials 
containing fresh medium. Males were placed in groups of up to 20 individuals on fresh media to 
prevent overcrowding and stored at 25°C until a sample size of 300 individuals for each cross 
had been collected.  Every 48 hours the flies were scored and media was changed whenever there 
was a death scored in a vial and twice per 7 day cycle. Flies were considered dead when no 
movement was observed when agitated (Staveley et al., 1990). Data was analyzed using the 
software Graphpad Prism 7 (Graphpad Software Inc.) using the log-rank test with significance 
considered at p < 0.05.  
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Locomotor assay 
A locomotor analysis was used to examine the motor control of flies throughout their 
lifespan. For this analysis, seventy male progeny were collected from each cross as described. 
Critical class males were collected on the day of eclosion and maintained in vials of ten flies per 
vial and kept at 25°C. Ideal conditions were maintained as for the survival analysis. These flies 
were transferred to new medium once per week throughout the experimentation. One week after 
collection and every seven days after, the climbing ability of five cohorts of flies per genotype 
was assessed. Ten trials were conducted for each cohort of ten flies per genotype. This provides a 
total of 500 trials per genotype per week. The flies were scored every seven days based on their 
ability to climb inside a 30 cm glass tube with a 1.5 cm diameter that was marked with five 2 cm 
sections along a buffer zone (Todd and Staveley, 2004). The scoring was based upon the height 
reached for two cm intervals of the tube. This climbing tube is described in Todd and Staveley 
(2008). A climbing index was calculated as: Climbing index = Σ nm/N where n is the number of 
flies at a given level, m is the score of the level which is between 1 and 5 and N is the total 
number of flies climbed in that trial. Data was analyzed using the software GraphPad Prism 7 
(GraphPad Software Inc.). A nonlinear regression curve was then generated with a 95% 
confidence interval to analyze the graphs of 5-climbing index as a function of time in days for 
each genotype. The slope for each graph represents the rate of decline in climbing ability and the 
Y-intercept represents the initial climbing ability and both of these parameters are calculated for 
each curve (Merzetti and Staveley, 2015). Slopes of the curves were compared using a 95% 
confidence interval. Curves were deemed significantly different if no overlap was found by the 
95% confidence interval.  
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Results 
Bioinformatic Analysis of Paris 
The Paris protein is conserved between vertebrates and invertebrates  
The multiple alignment of vertebrate and invertebrate versions of the Paris protein was 
conducted using sequences from D. melanogaster (NM_134996.4), C. quinquefasciatus 
(XM_001866910.1), M. musculus (XM_006506557.3) and H. sapiens (XP_005250012.1) 
(Figure 3). When comparing these four species, the Paris proteins show some similarities in 
residues among the species. The alignment showed common zinc finger associated domain, zinc 
finger C2H2 type domain and KRAB box. There is sufficient similarity in the D. melanogaster 
CG15436 to determine that it was the homologue for human zinc finger protein 746 (Paris).  
The phylogenetic tree (Figure 4) shows D. melanogaster CG15436 as having the highest 
distance value across all species used in the multiple alignment. These numbers represent the 
amount of genetic change through evolution. H. sapiens and M. musculus have the lowest 
amount of genetic change with values of 0.0309 and 0.03274, respectively. D. melanogaster has 
the highest amount of genetic change with a value of 0.36262. 
The vertebrate alignment (Figure 5B) included Homo sapiens zinc finger protein 746 
(accession number XP_005250012.1), Mus musculus zinc finger protein 746 (accession number 
XM_006506557.3), Danio rerio zinc finger protein (XM_017355354.1) and Gallus gallus zinc 
finger protein 398-like (accession number XM_015281107.1). The invertebrate alignment 
(Figure 5A) included Drosophila melanogaster CG15436 (accession number NM_134996.4), 
Copidosoma floridanum zinc finger protein 501-like (accession number XM_023390610.1), 
Culex quinquefasciatus zinc finger protein (accession number ZM_001846764.1) and Bombus 
impatiens zinc finger protein 271 (XM_012387283.2). 
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Figure 3: The protein Paris is slightly conserved between vertebrates and invertebrates.  
Clustal Omega multiple alignment of Paris proteins. Highlighted are the zinc finger associated 
domain (green), C2H2 type domain (red), and the KRAB box (blue).  “*” indicates amino acids 
that are identical in all sequences in the alignment. “:” indicates conserved substitutions. “.” 
indicates semi-conserved substitutions. BLAST used to obtain protein sequences and Pfam 
(Sanger Institute) used to obtain conserved domain areas. 
 
 
 
 
 
 
 
Figure 4: Phylogenetic Tree shows a high amount of genetic change between H. sapiens 
Paris and D. melanogaster CG15436. Numbers shown are the distance values which represent 
the number of substitutions as a proportion of the length of the alignment. The numbers are 
produced as the output of the multiple sequence alignment and represent the “length” of the 
branches. This is an indication of the evolutionary distance between the sequences.  
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Figure 5: The protein Paris is conserved across vertebrates as well as across invertebrates. 
A) Clustal Omega multiple alignment of Paris proteins in invertebrates. B) Clustal Omega 
multiple alignment of Paris proteins in vertebrates. Highlighted are the zinc finger associated 
domain (dark yellow), C2H2 type domain (pale yellow), the KRAB box (orange), Zinc finger 
double domain (blue), FOG zinc finger (green), SFP1 super family putative transcriptional 
repressor (pink) and zinc ribbon domain (purple).  “*” indicates amino acids that are identical in 
all sequences in the alignment. “:” indicates conserved substitutions. “.” indicates semi-
conserved substitutions. BLAST used to obtain protein sequences and NCBI Conserved Domains 
Database used to obtain conserved domain areas. 
 
 
 
 
 
 
 
 
Figure 6: Comparison of Drosophila melanogaster CG15436 protein (A) and Homo sapiens 
Paris protein (B) with conserved domains. Highlighted are the zinc finger associated domain 
(dark yellow), C2H2 type domain (pale yellow), the KRAB box (orange), zinc finger double 
domain (blue), and FOG zinc finger (green).   
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Effects of the knockdown of CG15436 and spargel 
Knockdown of CG15436 decreases climbing ability and lifespan 
To determine the effects of the knockdown of CG15436 on climbing ability and lifespan 
of D. melanogaster, the motoneuron specific driver D42-GAL4, the dopaminergic neuron 
specific driver TH-GAL4, the neuron specific driver ddc-GAL4 and the recombinant line ddc-
GAL4;UAS-parkRNAi were used.  When using the motoneuron specific driver D42-GAL4, there 
was a significant difference in the climbing ability between D42-GAL4;  
UAS-CG15436RNAi and the control D42-GAL4; UAS-lacZ (Figure 7, Table 2). When the 
dopaminergic neuron specific driver TH-GAL4 (Figure 9, Table 4), the neuron specific driver 
ddc-GAL4 (Figure 11, Table 6) and the recombinant line ddc-GAL4;UAS-parkRNAi (Figure 13, 
Table 7), there was no significant difference found in the climbing ability of flies with the 
knockdown of CG15436 when compared to the control UAS-lacZ. 
 The knockdown of spargel using the neuron-specific driver ddc-GAL4 resulted in a 
significant decrease in climbing ability when compared to the control UAS-lacZ (Figure 11, 
Table 6). There was no significant change in climbing ability of flies with the knockdown of 
spargel when compared to the control UAS-lacZ when using the driver lines D42-GAL4 (Figure 
7, Table 2), TH-GAL4 (Figure 9, Table 4) and ddc-GAL4;UAS-parkRNAi (Figure 13 and Table 8). 
The knockdown of CG15436 using the motorneuron specific driver D42-GAL4 and the 
recombinant line ddc-GAL4;UAS-parkRNAi resulted in a significant decrease in lifespan in 
comparison to the control UAS-lacZ (Figures 8 and 14). The median lifespan for flies with an 
knockdown of CG15436 with drivers D42-GAL4 and ddc-GAL4;UAS-parkRNAi are 62 and 60, 
respectively. These median lifespans are shorter than the control UAS-lacZ whose median 
lifespans are 64 and 72, respectively (Tables 3 and 9). The knockdown of CG15436 using the 
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dopaminergic neuron specific driver TH-GAL4 resulted in no significant change in the lifespan 
of flies when compared to the control UAS-lacZ (Figure 12, Table 5). The knockdown of 
CG51436 using the neuron specific driver ddc-GAL4 resulted in a significant increase in lifespan 
of the flies when compared to the control UAS-lacZ (Figure 10). The median lifespan for flies 
with an knockdown of CG15436 with driver ddc-GAL4 is 80 days. This median lifespan is 
significantly longer than the control UAS-lacZ whose median lifespan is 70 days (Table 7).  
The knockdown of spargel using the motoneuron specific driver D42-GAL4, the 
dopaminergic neuron specific driver TH-GAL4, the neuron specific driver ddc-GAL4 and the 
recombinant line ddc-GAL4;UAS-parkRNAi resulted in a significant decrease in lifespan in 
comparison to the control UAS-lacZ (Figures 8, 10, 12 and 14). The median lifespan for flies 
with an knockdown of CG15436 with drivers D42-GAL4, TH-GAL4, ddc-GAL4 and ddc-
GAL4;UAS-parkRNAi are 54, 64, 60 and 58, respectively. These median lifespans are shorter than 
the control UAS-lacZ whose median lifespans are 64, 70, 70 and 72, respectively (Tables 3, 5, 7 
and 9).   
 
Knockdown of CG15436 and spargel decreases bristle and ommatidia number  
 The eye of Drosophila melanogaster is a compound eye which has a very specific 
developmental pattern. Each eye is made up of approximately 800 ommatidia when undergoing 
normal development. The eye develops as a morphogenetic furrow which then migrates from the 
posterior imaginal disc to the anterior. The formation and differentiation of these cells then occur  
behind the furrow (Baker, 2001). If this process is disrupted, characteristic phenotypes are 
produced. These phenotypes are presented in many ways such as changes in ommatidia number 
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Figure 7: Directed motorneuron specific expression with knockdown of CG15436 and 
spargel causes a significant decrease in climbing ability over time as flies age. Directed RNA 
interference of CG15436 shows a significant decrease in climbing ability. Directed RNA 
interference of spargel shows no significant difference in climbing ability. Data was analyzed by 
a non-linear curve fit with 95% confidence intervals to determine significance. Error bars 
represent standard error.  
 
 
Table 2: Statistical analysis using a non-linear regression curve of locomotor ability with 
directed motorneuron-specific expression with knockdown of CG15436 and spargel.  
 
Genotype Slope ± SE 95% Confidence 
Intervals 
Significant 
compared to D42; 
UAS-lacZ 
D42-GAL4; UAS-
lacZ 
0.03711 
± 0.00453 
0.02869 – 
0.04677 
N/A 
D42-GAL4; UAS-
CG15436RNAi 
0.01749 
± 0.002233 
0.01325 – 
0.02185 
Yes ¯ 
D42-GAL4; UAS-
spargelRNAi 
0.03867 ±  
0.003811 
0.0316 –  
0.04642 
No 
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Figure 8: Directed motorneuron specific expression with knockdown of CG15436 and 
spargel causes a significant decrease in longevity. Longevity is depicted by percent survival. 
Significance is p < 0.05 using the log-rank test. Error bars represent standard error.  
 
 
 
 
 
 
 
 
Table 3: Log-rank statistical analysis of longevity of flies with directed motorneuron 
specific expression with knockdown of CG15436. Chi-square values and p-values were 
calculated using lacZ-expressing controls. 
 
Genotype Number of 
flies 
Median 
Survival 
(days) 
Chi – square 
value 
P – value Significant 
D42-GAL4; 
UAS-lacZ 
141 64 N/A N/A N/A 
D42-GAL4; 
UAS-
CG15436RNAi 
290 62 6.191 0.0128 Yes ¯ 
D42-GAL4; 
UAS-
spargelRNAi 
388 54 27.51 <0.0001 Yes ¯ 
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Figure 9: Directed dopaminergic neuron specific expression with knockdown of CG15436. 
Knockdown of CG15436 does not show a significant decrease in climbing ability over time. 
Data was analyzed by a non-linear curve fit with 95% confidence intervals to determine 
significance. Error bars represent standard error. 
 
 
 
 
Table 4: Statistical analysis using a non-linear regression curve of locomotor ability of flies 
with dopaminergic neuron specific expression with knockdown of CG15436.  
 
Genotype Slope ± SE 95% Confidence 
Intervals 
Significant 
TH-GAL4; UAS-lacZ 0.02395 ± 0.001932 0.02055 – 0.0275 N/A 
TH-GAL4; UAS-
CG15436RNAi 
0.02006 ± 0.002093 0.01628 – 0.02397 No 
TH-GAL4; UAS-
spargelRNAi 
0.02821 ± 0.00205 0.02454 – 0.03209 No 
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Figure 10: Directed dopaminergic neuron specific expression with knockdown  
of CG15436 does not cause a significant increase in longevity and knockdown of spargel 
causes a significant decrease in longevity. Longevity is depicted by percent survival. 
Significance is p < 0.05 using the log-rank test. Error bars represent standard error.  
 
 
 
 
Table 5: Log-rank statistical analysis of longevity of flies with directed dopaminergic 
neuron specific expression with knockdown of CG15436 and spargel. Chi-square values and 
p-values were calculated using lacZ-expressing controls. 
 
Genotype Number of 
flies 
Median 
Survival 
(days) 
Chi – square 
value 
P – value Significant 
TH-GAL4; 
UAS-lacZ 
222 70 N/A N/A N/A 
TH-GAL4; 
UAS-
CG15436RNAi 
199 74 2.198 0.1382 No 
TH-GAL4; 
UAS-
spargelRNAi 
261 64 21.59 <0.0001 Yes¯ 
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Figure 11: Directed neuron specific expression with knockdown of CG15436 does not cause 
a significant decrease in climbing ability and with knockdown of spargel does cause a 
significant decrease in climbing ability over time as flies age. Neuron specific expression of 
CG15436 does not show a significant decrease in climbing ability. Data was analyzed by a non-
linear curve fit with 95% confidence intervals to determine significance. Error bars represent 
standard error.  
 
 
 
 
Table 6: Statistical analysis using a non-linear regression curve of locomotor ability of flies 
with neuron specific expression with knockdown of and CG15436 and spargel. 
 
Genotype Slope ± SE 95% Confidence 
Intervals 
Significant 
ddc-GAL4; UAS-lacZ 0.03219 ± 0.002762 0.02721 – 0.03744 N/A 
ddc-GAL4; UAS-
CG15436RNAi 
0.02767 ± 0.001791 0.0242 – 0.03126 No 
ddc-GAL4; UAS-
spargelRNAi 
0.05642 ± 0.005439 0.04653 – 0.06734 Yes ¯ 
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Figure 12: Directed neuron specific expression with knockdown of CG15436 causes a 
significant increase in longevity and directed neuron specific expression with knockdown of 
spargel causes a significant decrease in longevity. Longevity is depicted by percent survival. 
Significance is p < 0.05 using the log-rank test. Error bars represent standard error.  
 
 
 
Table 7: Log-rank statistical analysis of longevity of flies with directed neuron specific 
expression with knockdown of spargel and CG15436. Chi-square values and p-values were 
calculated using lacZ-expressing controls. 
 
Genotype Number of 
flies 
Median 
Survival 
(days) 
Chi-square 
value 
P-value Significant 
ddc-GAL4; 
UAS-lacZ 
253 70 N/A N/A N/A 
ddc-GAL4; 
UAS-
CG15436RNAi 
278 80 28.07 <0.0001 Yes ­ 
ddc-GAL4; 
UAS-
spargelRNAi 
274 60 5.8 0.0160 Yes ¯ 
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Figure 13: Directed neuron specific expression with knockdown of parkin shows that 
CG15436 and spargel do not cause a significant decrease in climbing ability over time as 
flies age. Neuron specific expression of CG15436 does not show a significant decrease in 
climbing ability. Data was analyzed by a non-linear curve fit with 95% confidence intervals to 
determine significance. Error bars represent standard error.  
 
 
 
 
Table 8: Statistical analysis using a non-linear regression curve of locomotor ability of flies 
with neuron specific expression with knockdown of parkin and CG15436 or spargel. 
 
Genotype Slope ± SE 95% Confidence 
Intervals 
Significant 
ddc-GAL4;UAS-
parkRNAi; UAS-lacZ 
0.03245 ± 0.02488 -0.02106 – 0.08766 N/A 
ddc-GAL4;UAS-
parkRNAi; UAS-
CG15436RNAi 
0.02368 ± 0.007278 0.008233 – 0.0391 No 
ddc-GAL4;UAS-
parkRNAi; UAS-
spargelRNAi 
0.05917 ± 0.01319 0.03226 – 0.08941 No 
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Figure 14: Directed neuron specific expression with knockdown of parkin and CG15436 or 
spargel causes a significant decrease in longevity. Longevity is depicted by percent survival. 
Significance is p < 0.05 using the log-rank test. Error bars represent standard error.  
 
 
 
Table 9: Log-rank statistical analysis of longevity of flies with directed neuron specific 
expression with knockdown of parkin and CG15436 or spargel. Chi-square values and p-
values were calculated using LacZ-expressing controls. 
 
Genotype Number of 
flies 
Median 
Survival 
(days) 
Chi-square 
value 
P-value Significant 
ddc-
GAL4;UAS-
parkRNAi; 
UAS-lacZ 
218 72 N/A N/A N/A 
ddc-
GAL4;UAS-
parkRNAi; 
UAS-
CG15436RNAi 
283 60 9.37 0.0022 Yes ¯ 
ddc-
GAL4;UAS-
parkRNAi; 
UAS-
spargelRNAi 
254 58 11.04 0.0009 Yes ¯ 
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and bristle number. Biometric analysis was conducted to determine the phenotypic changes in 
the eye to determine the effects of altering gene expression such as the knockdown of CG15436. 
These phenotypic changes include a change in the number of ommatidia or bristles when 
compared to the control. GMR-GAL4 is a GAL4 transgene used to determine the effects of the 
knockdown of CG15436 and spargel in the compound eye. A recombinant driver, GMR-GAL4; 
UAS-parkRNAi was also used which consisted of GMR-GAL4 with the knockdown of parkin. 
Biometric analysis of the scanning electron micrographs shows that there is a significant 
decrease in ommatidia number and bristle number when CG15436 and spargel are knocked 
down with the driver GMR-GAL4 (Figures 15 and 16). When the knockdown of CG15436 and 
spargel is driven by GMR-GAL4 the average number of ommatida per eye was shown to be 
682.9 ± 10.46 and 619.4 ± 6.058, respectively. This is compared to the control lacZ where the 
average number of ommatidia per eye is 712.1 ± 7.326. The average bristle number for CG15436 
and spargel are 491.9 ± 17.17 and 462.2 ± 7.071, respectively. The control lacZ had a 
significantly higher number of bristles with an average of 539.5 ± 11.69 (Table 10). There was 
no significant difference in ommatidia number or bristle number detected in the knockdown of 
CG15436 and spargel with the driver line GMR-GAL4;UAS-parkRNAi (Figure 17 and Table 11).  
 
Effects of the overexpression of CG15436 
Overexpression of CG15436 decreases climbing ability and increases longevity 
 To determine the effects of the overexpression of CG15436 on climbing ability and 
lifespan of Drosophila melanogaster, the motorneuron specific driver D42-GAL4, the neuron 
specific driver ddc-GAL4 and the recombinant line ddc-GAL4;UAS-parkRNAi were used.  When 
using the neuron specific driver ddc-GAL4, there was no significant difference in the climbing  
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Figure 15: Knockdown of CG15436 and spargel under the control of eye specific drivers 
influence ommatidia and bristle number. Scanning electron micrographs of A: GMR-GAL4; 
UAS-lacZ, B: GMR-GAL4; UAS-CG15436RNAi, C: GMR-GAL4; UAS-spargelRNAi, D: GMR-
GAL4;UAS-parkRNAi; UAS-lacZ, E: GMR-GAL4;UAS-parkRNAi; UAS-CG15436RNAi, F: GMR-
GAL4;UAS-parkRNAi; UAS-spargelRNAi. GMR-GAL4 is an eye specific driver and GMR-
GAL4;UAS-parkRNAi is an eye specific driver with an knockdown of parkin.  
 
 
 
 
 
 
 
 
 
 
A B C 
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A       B 
 
 
Figure 16: Biometric analysis of the compound eye under the influence of eye specific 
expression with the knockdown of CG15436 and spargel. Knockdown of CG15436 and 
spargel in the eye significantly decreases ommatidia number (A) and bristle number (B). 
Significance is <0.05. Error bars represent standard error of the mean. UAS-lacZ crosses are the 
comparison controls.  
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A       B 
 
Figure 17: Biometric analysis of the compound eye under the influence of eye specific 
expression with the knockdown of CG15436 and spargel with a recombinant driver with the 
knockdown of parkin. Knockdown of CG15436 and spargel in the eye does not cause a 
significant decrease ommatidia number (A) and bristle number (B). Significance is <0.05. Error 
bars represent standard error of the mean. UAS-lacZ crosses are the comparison controls. 
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Table 10: Summary of ommatidia number and bristle number when CG15436 and spargel 
are knocked down in the compound eye.  
 
Genotype Sample Size 
(n) 
Mean ± SEM P-value 
compared to 
control 
Significant 
Ommatidia  
Number 
    
GMR-GAL4; 
UAS-lacZ 
10 712.1 ± 7.326 N/A N/A 
GMR-GAL4; 
UAS-spargelRNAi 
10 619.4 ± 6.058 <0.0001 Yes¯ 
GMR-GAL4; 
UAS-CG15436RNAi 
10 682.9 ± 10.46 0.0346 Yes¯ 
Bristle Number     
GMR-GAL4; 
UAS-lacZ 
10 539.5 ± 11.69 N/A N/A 
GMR-GAL4; 
UAS-spargelRNAi 
10 462.2 ± 7.071 <0.0001 Yes¯ 
GMR-GAL4; 
UAS-CG15436RNAi 
10 491.9 ±17.17 0.0342 Yes¯ 
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Table 11: Summary of ommatidia number and bristle number when CG15436, spargel and 
parkin are knocked down in the compound eye.  
 
Genotype Sample Size (n) Mean ± SEM P-value 
compared to 
control 
Significant 
Ommatidia  
Number 
    
GMR-GAL4; 
UAS-parkRNAi; 
UAS-lacZ 
10 705.4 ± 8.582 N/A N/A 
GMR-GAL4; 
UAS-parkRNAi; 
UAS-spargelRNAi 
10 705.4 ± 8.582 >0.9999 No 
GMR-GAL4; 
UAS-parkRNAi; 
UAS-
CG15436RNAi 
10 686.9 ± 9.556 0.1669 No 
Bristle Number     
GMR-GAL4;UAS-
parkRNAi; UAS-
lacZ 
10 560 ± 6.326 N/A N/A 
GMR-GAL4;UAS-
parkRNAi; UAS-
spargelRNAi 
10 541.8 ± 7.261 0.0750 No 
GMR-GAL4;UAS-
parkRNAi; UAS-
CG15436RNAi 
10 542.1 ± 9.197 0.1262 No 
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ability of flies between ddc-GAL4; UAS-CG15436ORF when compared to the control ddc- GAL4; 
UAS-lacZ (Figure 20, Table 14). When the motoneuron specific driver D42-GAL4 and the 
recombinant line ddc-GAL4;UAS-parkRNAi, there was a significant difference found in the 
climbing ability of flies with the overexpression of CG15436 when compared to the control 
UAS-lacZ (Figures 18 and 22, Table 12 and 16). 
The overexpression of CG15436 using the motoneuron specific driver D42-GAL4 and the 
neuron specific driver ddc-GAL4 resulted in a significant increase in lifespan in comparison to 
the control UAS-lacZ (Figures 19 and 21). The median lifespan for flies with an overexpression 
of CG15436 with driver D42-GAL4 and ddc-GAL4 is 74 for both. This median lifespan is shorter 
than the control UAS-lacZ with D42-GAL4 and ddc-GAL4 whose median lifespan is 64 and 62, 
respectively (Table 13 and 15). There was no significant difference in the lifespan of flies using 
the neuron specific driver ddc-GAL4;UAS-parkRNAi (Figure 23, Table 17).   
 
Overexpression of CG15436 decreases bristle and ommatidia number  
 The eye of Drosophila melanogaster is a compound eye which has a very specific 
developmental pattern. Each eye is made up of approximately 800 ommatidia when undergoing 
normal development. The eye develops as a morphogenetic furrow which then migrates from the  
posterior imaginal disc to the anterior. The formation and differentiation of these cells then occur 
behind the furrow (Baker, 2001). If this process is disrupted, characteristic phenotypes are 
produced. These phenotypes are presented in many ways such as changes in ommatidia number 
and bristle number. Biometric analysis was done to determine the phenotypic changes in the eye 
to determine the effects of altering gene expression such as the overexpression of CG15436. 
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Figure 18: Directed motorneuron specific overexpression of CG15436 causes a significant 
decrease in climbing ability over time as flies age. Overexpression of CG15436 shows a 
significant decrease in climbing ability. Data was analyzed by a non-linear curve fit with 95% 
confidence intervals to determine significance. Error bars represent standard error.  
 
 
Table 12: Statistical analysis using a non-linear regression curve of locomotor ability with 
directed motorneuron-specific overexpression of CG15436.  
 
Genotype Slope ± SE 95% Confidence 
Intervals 
Significant 
D42; UAS-lacZ 0.03711 ± 0.00453 0.02869 – 0.04677 N/A 
D42; UAS-
CG15436ORF 
0.02336 ± 0.004957 0.01429 – 0.0333 Yes¯ 
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Figure 19: Directed motorneuron specific overexpression of CG15436 causes a significant 
increase in longevity. Longevity is depicted by percent survival. Significance is p < 0.05 using 
the log-rank test. Error bars represent standard error.  
 
 
 
 
 
 
 
 
Table 13: Log-rank statistical analysis of longevity of flies with directed motorneuron 
specific expression with overexpression of CG15436. Chi-square values and p-values were 
calculated using lacZ-expressing controls. 
 
Genotype Number of 
flies 
Median 
Survival 
(days) 
Chi – square 
value 
P – value Significant 
D42; UAS-
lacZ 
141 64 N/A N/A N/A 
D42; UAS-
CG15436ORF 
273 74 16.93 <0.0001 Yes ­ 
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Figure 20: Directed neuron specific expression with overexpression of CG15436 does not 
cause a significant decrease in climbing ability over time as flies age. Neuron specific 
expression of CG15436 does not show a significant decrease in climbing ability. Data was 
analyzed by a non-linear curve fit with 95% confidence intervals to determine significance. Error 
bars represent standard error.  
 
 
 
 
Table 14: Statistical analysis using a non-linear regression curve of locomotor ability of 
flies with neuron specific expression with overexpression of CG15436. 
 
Genotype Slope ± SE 95% Confidence 
Intervals 
Significant 
ddc-GAL4; UAS-lacZ 0.03219 ± 0.002762 0.02721 – 0.03744 N/A 
ddc-GAL4; UAS-
CG15436ORF 
0.02589 ± 0.002337 0.02156 – 0.0304 No 
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Figure 21: Directed neuron specific expression with overexpression of CG15436 causes a 
significant increase in longevity.  Longevity is depicted by percent survival. Significance is p < 
0.05 using the log-rank test. Error bars represent standard error.  
 
 
 
 
 
 
Table 15: Log-rank statistical analysis of longevity of flies with neuron specific expression 
with overexpression of CG15436. Chi-square values and p-values were calculated using lacZ-
expressing controls. 
 
Genotype Number of 
flies 
Median 
Survival 
(days) 
Chi – square 
value 
P – value Significant 
ddc-GAL4; 
UAS-lacZ 
265 62 N/A N/A N/A 
ddc-GAL4; 
UAS-
CG15436ORF 
115 74 21.47 <0.0001 Yes­ 
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Figure 22: Directed neuron specific expression with knockdown of parkin and 
overexpression of CG15436 causes a significant decrease in climbing ability over time as 
flies age. Neuron specific expression of CG15436 does not show a significant decrease in 
climbing ability. Data was analyzed by a non-linear curve fit with 95% confidence intervals to 
determine significance. Error bars represent standard error.  
 
 
 
 
Table 16: Statistical analysis using a non-linear regression curve of locomotor ability of 
flies with neuron specific expression with knockdown of parkin and overexpression of 
CG15436. 
 
Genotype Slope ± SE 95% Confidence 
Intervals 
Significant 
ddc-GAL4;UAS-
parkRNAi; UAS-lacZ 
0.03393 ± 0.003998 0.02683 – 0.04153 N/A 
ddc-GAL4;UAS-
parkRNAi; UAS-
CG15436ORF 
0.0212 ± 0.002015 0.01749 – 0.02504 Yes¯ 
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Figure 23: Directed neuron specific expression with knockdown of parkin and 
overexpression of CG15436 does not cause a significant change in longevity.  Longevity is 
depicted by percent survival. Significance is p < 0.05 using the log-rank test. Error bars represent 
standard error.  
 
 
 
 
 
 
Table 17: Log-rank statistical analysis of longevity of flies with neuron specific expression 
with knockdown of parkin and overexpression of CG15436. Chi-square values and p-values 
were calculated using lacZ-expressing controls. 
 
Genotype Number of 
flies 
Median 
Survival 
(days) 
Chi – square 
value 
P – value Significant 
ddc-GAL4; 
UAS-
parkRNAi; 
UAS-lacZ 
99 62 N/A N/A N/A 
ddc-GAL4; 
UAS-
parkRNAi; 
UAS-
CG15436ORF 
88 62 1.837 0.1753 No 
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GMR-GAL4 is a GAL4 transgene used to determine the effects of the overexpression of 
CG15436 in the compound eye. A recombinant driver, GMR-GAL4; UAS-parkRNAi was used 
which consisted of GMR-GAL4 with the knockdown of parkin. Biometric analysis of the 
scanning electron micrographs show that there is a significant decrease in ommatidia number and 
bristle number when CG15436 is overexpressed with the driver GMR-GAL4; UAS-parkRNAi  
 (Figure 24 and 25). When the overexpression of CG15436 is driven by GMR-GAL4; UAS-
parkRNAi  the average number of ommatidia per eye was shown to be 669.7 ± 6.549. This is 
compared to the control lacZ where the average number of ommatidia per eye is 734.2 ± 15.44. 
The  
overexpression of CG15436 with the driver GMR-GAL4; UAS-parkRNAi results in a significant 
decrease in bristle number. The average bristle number for CG15436 is 518.6 ± 9.597. The 
control lacZ had a significantly higher number of bristles with an average of 573.3 ± 10.99 
(Table 18). 
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Figure 24: Overexpression of CG15436 under the control of eye specific drivers with 
knockdown of parkin influence ommatidia and bristle number. Scanning electron 
micrographs of A:  GMR-GAL4;UAS-parkRNAi; UAS-lacZ, B: GMR-GAL4;UAS-parkRNAi; UAS-
CG15436ORF. GMR-GAL4;UAS-parkRNAi is an eye specific driver with an knockdown of parkin.  
 
 
 
 
A      B 
 
Figure 25: Biometric analysis of the compound eye under the influence of eye specific 
expression with the overexpression of CG15436 with a recombinant driver with the 
knockdown of parkin. Overexpression of CG15436 with knockdown of parkin in a driver line 
in the eye causes a significant decrease ommatidia number (A) and bristle number (B). 
Significance is <0.05. Error bars represent standard error of the mean. UAS-lacZ crosses are the 
comparison controls. 
 
A B 
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Table 18: Summary of ommatidia number and bristle number when CG15436 is 
overexpressed and parkin is knocked down in the compound eye. 
 
Genotype Sample Size (n) Mean ± SEM P-value 
compared to 
control 
Significant 
Ommatidia 
Number 
    
GMR-
GAL4;UAS-
parkRNAi; UAS-
lacZ 
10 734.2 ± 15.44 N/A N/A 
GMR-
GAL4;UAS-
parkRNAi; UAS-
CG15436ORF 
10 669.7 ± 6.549 0.0012 Yes ¯ 
Bristle Number     
GMR-
GAL4;UAS-
parkRNAi; UAS-
lacZ 
10 573.3 ± 10.99 N/A N/A 
GMR-
GAL4;UAS-
parkRNAi; UAS-
CG15436ORF 
10 518.6 ± 9.597 0.0015 Yes ¯ 
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Discussion 
 
Parkinson disease (PD) is a neurodegenerative movement disorder that affects 1 to 2% of 
the human population over the age of 65. This makes PD one of the most prevalent diseases in 
our world today (Weintraub et al., 2008). Characteristics of this disease include resting tremor, 
rigidity, bradykinesia and postural instability (Trinh et al., 2014). Mitochondrial autophagy 
(mitophagy) is important in metabolism as it is involved in adjusting mitochondrial mass and 
removing mitochondria during differentiation processes. The failure of mitochondrial 
surveillance supported by autophagy is linked to PD (Franz et al., 2015). Paris is a gene of 
interest in PD research due to its involvement in a pathway with parkin and PCG-1α, 
inactivation of both parkin and PCG-1α have been associated with PD. Paris is required for the 
loss of dopaminergic neurons in adult conditional parkin knockout mice (Stevens et al., 2015).  A 
potential Paris homologue in Drosophila has not been widely studied in research. Potential Paris 
homologues have been investigated (Merzetti and Staveley, 2016) and CG15436, my gene of 
interest, was identified as the most likely Paris homologue in D. melanogaster. We must further 
study the role of Paris and its interactions in these pathways in order to open up new 
opportunities for causes and treatments of this disease. This study explored various aspects of the 
potential D. melanogaster homologue of Paris. CG15436 was ectopically expressed as well as 
knocked down in D. melanogaster to determine its effects on cell death, cell growth, longevity 
and locomotor ability.   
 
Drosophila CG15436 is conserved across mammalian Paris 
Bioinformatic analysis was conducted to determine the similarity of Paris homologues 
across vertebrates and invertebrates.  Through this bioinformatics analysis, it is suggested that 
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the Drosophila melanogaster CG15436 and Homo sapiens Paris are functional homologues. 
CG15436 in Drosophila and the zinc finger protein 746 (Paris) in humans share structural 
features which include the zinc finger associated domain and the C2H2 type domain. However, 
the placement of these domains in the proteins are different from one another as is the size of the 
proteins as a whole. CG15436 in Drosophila is a much smaller protein in comparison to the zinc 
finger protein 746 in humans. The KRAB box that was identified in H. sapiens and M. musculus 
was not identified in Drosophila. This KRAB box is a highly conserved motif that is found in 
over one third of all mammalian zinc-finger transcription factors. CG15436 has previously been 
characterized as encoding zinc-finger-containing proteins (Merzetti and Staveley, 2017). With 
the presence of conserved domains in H. sapiens Paris and D. melanogaster CG15436, there is 
evidence of homology and, as a result, further evidence of similar function in the two species. 
The phylogenetic tree constructed with Clustal Omega (Figure 4) gives some insight into the 
homology of the gene across species. The distance values are the smallest between H. sapiens 
and M. musculus. Comparisons with D. melanogaster show the largest numbers, which indicates 
a larger amount of genetic change across more distantly related species. The numbers are 
produced as the output of the multiple sequence alignment and represent the “length” of the 
branches. This is an indication of the evolutionary distance between the sequences.  
Different families of zinc finger proteins are expanded in different eukaryotic lineages. 
These expansions include the KRAB family in mammals and the ZAD family in dipterian 
insects. There is clustering at specific chromosome locations and lineage specific enrichment in 
both these families of zinc finger proteins (Krystel and Ayyanathan, 2012). Zinc-finger proteins 
containing the KRAB are the largest single family of transcriptional regulators in mammals. 
These proteins contain a DNA-binding domain and a KRAB domain (Urrutia, 2003). Zinc finger 
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proteins are more expanded in higher eukaryotic species. The evolutionary expansion that 
occurred in humans included zinc-finger proteins that contain evolutionarily conserved SCAN or 
KRAB domains. These domains are restricted to vertebrate species (Chung et al., 2002). Due to 
this divergence of proteins which led to different domains in vertebrates compared to 
invertebrates, one part of the alignment shows a conservation among proteins in Drosophila 
melanogaster and Homo sapiens. The bioinformatics analysis suggests that the Drosophila 
melanogaster CG15436 and Homo sapiens Paris are functional homologues.       
 
Effect of CG15436 knockdown in Drosophila 
 The D. melanogaster eye is made up of a repetitive pattern of ommatidia. The 
differentiation of the specialized cells that become the photoreceptors starts in the eye imaginal 
disc with clusters of differentiating neurons. Usually, the fully formed adult D. melanogaster eye 
has in the range of 750 to 800 ommatidia. There are 8 photoreceptors which are photosensitive 
neurons inside each ommatidia. This amounts to a total of over 6000 neurons in each D. 
melanogaster eye (Frankfort and Mardon, 2002). Neurodegeneration can be measured using the 
eye structure due to its close association with neurons (Marsh et al., 2003). This highly regulated 
pattern of the eye allows any defect, big or small, to be detected during the process of neural 
development in ommatidia and bristle number.  
 My experiments demonstrate that in Drosophila melanogaster, knockdown of CG15436 
and spargel directly in the eye through eye-specific expression as well as in concert with the 
knockdown of parkin results in a decrease in both ommatidia number and bristle number. The 
decrease in ommatidia number and bristle number is slight but significant, as it is demonstrated 
through biometric analysis. This decrease can be due to an increase in apoptosis or a decrease in 
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cell growth and survival signalling that is required for normal and successful eye development. 
In previous studies, Paris has been shown to be required for the loss of dopaminergic neurons in 
parkin knockout mice (Stevens et al., 2015). Therefore, when both parkin and Paris are knocked 
down, there may be loss of regulation of the survival of these neurons and neurodegeneration 
would occur. This would be present in the phenotype of the eye through these experiments, in 
terms of bristle and ommatidia number. Paris is a regulator of PGC-1α and therefore with the 
knockdown of Paris, PGC-1α (spargel in D. melanogaster) will not be regulated in its pathway. 
PGC-1α is responsible for mitochondrial function and defects in mitochondria is a characteristic 
of Parkinson disease (Stevens et al., 2015). With the knockdown of CG15436, spargel may not 
be regulated and mitochondrial defects could occur and with the knockdown of spargel itself. 
Therefore, a potential increase in apoptosis may be the reason for the decrease in ommatidia and 
bristle number when CG15436 and spargel are knocked down.  
 Longevity assays were conducted to determine the effects of the knockdown of CG15436 
and spargel. Varied results were obtained in the experiments. However, the pathways and 
functions of these genes are indicative of the results found in this study.  
When there is a directed motorneuron specific expression (D42-GAL4) and directed 
neuron specific expression with the knockdown of parkin in the driver line, there is a significant 
decrease in the longevity of flies that are knocked down by CG15436 or spargel. When there is 
directed dopaminergic neuron specific expression (TH-GAL4), there is no significant difference 
in the longevity of flies with the knockdown of CG15436 although there is a decrease in the 
longevity of flies with an knockdown of spargel. For the directed neuron specific expression 
(ddc-GAL4) there is an increase in the longevity of flies that have knockdown of CG15436 and a 
decrease in the longevity of flies that have an knockdown of spargel.  
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Similar to our results, previous research conducted by Merzetti and Staveley (2016) has 
shown similar results for the increase in lifespan of CG15436RNAi when crossed to the directed 
neuron specific driver ddc-GAL4. The knockdown of CG15436 should result in an increase in 
mitochondrial biogenesis in its pathway with spargel.  
I have significantly extended the investigation into CG15436 through use of 2 other 
drivers TH-GAL4 and D42-GAL4 and furthermore, though use of a complex line, ddc-
GAL4;UAS-parkRNAi, a model of Parkinson Disease.  Using the D42-GAL4 driver, there is 
motorneuron expression. The decrease in lifespan is not expected as this would mean there 
would be a decrease in mitochondrial biogenesis when CG15436 is knocked down in the 
pathway. The complex line which showed a decrease in the lifespan of flies when CG15436 was 
knocked down was ddc-GAL4;UAS-parkRNAi. This line has neuron specific expression with an 
knockdown of parkin. It has been shown in the pathway that a decrease in parkin leads to an 
increase in Paris and then a decrease in PGC-1a (spargel in D. melanogaster). With an 
knockdown of parkin as well as CG15436 (the potential Paris homologue), there would be no 
regulation of spargel in the pathway. This may have detrimental effects and therefore cause the 
decrease in lifespan in the flies with the knockdown of both of these genes. The inactivation of 
parkin has been shown to contribute to the pathogenesis of Parkinson disease. PGC-1α is a 
transcriptional repressor that is involved in mitochondrial function (Stevens et al., 2015). It 
controls the transcription of many genes that are involved in cellular metabolism, mitochondrial 
biogenesis and mitochondrial respiration (Shin et al., 2011). When PGC-1α is repressed by the 
accumulation of Paris it is likely a hindrance of the production of mitochondrial proteins 
(Stevens et al., 2015).  
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The decrease in lifespan of the flies when spargel was knocked down was a constant 
result across all drivers used in the longevity experiments. This can be explained by the role of 
spargel in the function of mitochondria and cellular mechanisms. The knockdown of spargel 
results in the lack of functional mitochondria. Mitochondrial defects are a characteristic of PD 
and therefore explain the shorter lifespan of these flies when compared to the lacZ-expressing 
controls (Stevens et al., 2015). The pathways and functions of these genes are therefore 
indicative of the results found in this study. 
 Due to the characteristics of PD that include resting tremor and rigidity, climbing 
analyses were conducted to determine the effects genes have on locomotor ability of Drosophila. 
When using a motorneuron specific driver (D42-GAL4), there was a very significant decrease in 
the climbing ability of flies with an knockdown of CG15436, compared to the lacZ-expressing 
control. In contrast to my results, a study using a c-Abl inhibitor which reduces c-Abl activation 
and therefore reduces the levels of Paris and represses the expression of PGC-1a show that these 
cause an improvement in motor and cognitive functions in PD patients. C-Abl is an Abelson non-
receptor tyrosine kinase and is involved in neurodegerative diseases such as PD. The activation 
of c-Abl is increased in PD (Zhou et al., 2017). Directed dopaminergic neuron specific 
expression (TH-GAL4), directed neuron specific expression (ddc-GAL4) and directed neuron 
specific expression with an knockdown of parkin in the complex line (ddc-GAL4;UAS-parkRNAi) 
showed no significant decrease in climbing ability in flies with an knockdown of CG15436. For 
the flies with an knockdown of spargel, there was a significant decrease in the climbing ability 
of the flies with directed neuron specific expression (ddc-GAL4). For motorneuron specific 
expression, dopaminergic neuron expression and directed neuron specific expression with an 
knockdown of parkin, there was no significant change in the climbing ability of the flies. When 
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there is an accumulation of Paris, it becomes a pathogenic substrate. This accumulation occurs in 
patients with PD. When this accumulation occurs, PGC-1a is repressed (Shin et al., 2011). This 
should produce similar effects to having an knockdown of spargel in flies. PGC-1a is a 
transcriptional coactivator and is involved in the transcription of genes involved in metabolic 
processes such as mitochondrial biogenesis (Shin et al., 2011). If this coactivator is repressed, 
then these processes may not be carried out properly. This can be detrimental to cells and 
therefore affect many other developmental processes such as cognitive and motor ability.  
 
Effect of CG15436 overexpression in Drosophila 
 Overexpression of CG15436 under the control of the eye specific driver, GMR-GAL4, 
with an knockdown of parkin in the driver causes a significant decrease in the number of 
ommatidia and bristles in the eye of Drosophila melanogaster. The slight decrease in the 
numbers of ommatidia and bristles has been determined through biometric analysis. This 
decrease may be due to influence of the mechanism that includes parkin and PGC-1a. Parkin is 
an ubiquitin E3 ligase that is associated with autosomal recessive PD as well as sporadic PD. 
When there is a loss of parkin’s ubiquitin E3 ligase activity, there is a loss of dopamine neurons 
which is linked to PD. Paris is shown to be involved in the loss of dopamine neurons. When 
there is a deletion in parkin, Paris accumulates and a progressive loss of dopamine neurons 
occurs. Paris overexpression which occurs in adult conditional parkin knockout mice results in 
defects in PGC-1a. The maintenance of mitochondrial biogenesis is very critical for dopamine 
neuron survival (Stevens et al., 2015). This knockout of parkin and overexpression of Paris is 
replicated with the flies used in this experiment. Flies used have an knockdown of parkin and an 
overexpression of CG15436, the potential Drosophila homologue of Paris. These results suggest 
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that the loss of parkin and the overexpression of CG15436 impairs mitochondrial biogenesis, 
which leads to a decrease in mitochondrial function and an increase  in cell death. This is 
characterized by the eye phenotype with decreased number of ommatidia and bristles when 
compared to the lacZ control.   
 Standard longevity assays were also conducted to determine the effects of overexpression 
of CG15436 on the lifespan of Drosophila. Overexpression of CG15436 with motorneuron-
specific and neuron-specific overexpression causes a significant increase in lifespan when 
compared to the lacZ-expressing control. This was not an expected result in this experiment. An 
accumulation of Paris makes it an attractive pathogenic substrate. However, it is not certain 
whether Paris is the only contributing mechanism to the degeneration of dopamine neurons (Shin 
et al., 2011). Therefore, if there are other contributing factors to this neurodegeneration, solely 
overexpressing Paris may not cause the expected decrease in lifespan. There may be a sort of 
counterbalancing effect occurring with the other parts of the pathway including parkin and 
spargel (Shin et al., 2011). More research into the potential of this counterbalancing effect must 
be done to fully understand the expression of this gene.   
 Due to the characteristics of PD such as rigidity and resting tremor, locomotor analysis 
was conducted to determine the climbing ability of Drosophila over time. Consistent with these 
characteristics of PD and the study of Paris’ involvement in PD genetic pathways, there is a 
significant decrease in climbing ability of flies with an overexpression of CG15436 when 
crossed with the driver line D42-GAL4 and the complex line ddc-GAL4;UAS-parkRNAi. There is a 
progression of neuronal degradation and Lewy bodies in the cerebral cortex and limbic structures 
of PD patients (de Lau and Breteler, 2006). As a consequence, PD leads to the loss of the 
cognitive and locomotor function of those affected. The identification of the new parkin-
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interacting substrate provides insights into the molecular mechanisms involved in the 
neurodegeneration due to its relation to the inactivation of parkin in PD patients (Shin et al., 
2011). One of the major drivers in the degeneration of dopaminergic neurons and the defects in 
mitochondrial biogenesis is the Paris-mediated downregulation of PGC-1α which is due to the 
absence of parkin. This is then a hinderance of mitochondrial protein production. An increase in 
the levels of Paris in PD patients are likely a contributing factor to the pathogenesis of this 
neurodegenerative disease (Stevens et al., 2015). CG15436 overexpression in flies producing a 
decreased climbing ability in motorneuron and neuron specific driver lines makes it a potential 
homologue for Paris. CG15436 knockdown produces similar effects in Drosophila as what 
would be expected to happen in PD patients with an overexpression of Paris. The climbing 
ability of the flies is comparable to the motor functions of humans. As well, the neuron specific 
driver ddc-GAL4 which was combined with an knockdown line of parkin and crossed to 
CG15436 further demonstrates the degeneration and defects in mitochondrial biogenesis that 
occurs when there is an absence of parkin and a subsequent accumulation of Paris in PD patients. 
The decreased climbing ability of the flies shown to be significant in this experiment is relatable 
to the symptoms of PD in these patients. Flies have phenotypes that are consistent with 
modelling PD in Drosophila through alteration of Paris. One of the drivers, ddc-GAL4, which 
has neuron specific expression did not show a significant decrease in the climbing ability of the 
flies as was shown with the other two drivers. As explained previously, there may be other 
contributing factors to this neurodegeneration in the Paris-associated pathway. This may include 
a counterbalancing effect with other parts of the pathway including parkin and spargel (Shin et 
al., 2011). In addition, CG15436 may not be overexpressed as strongly with certain drivers such 
as the neuron specific driver, ddc-GAL4, used in this part of the experiment.  
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Conclusion 
With the present study, the foundation has been done for the characterization and identification 
of the Drosophila melanogaster homologue of Paris. Although this protein is not highly 
conserved at the amino acid level due to the evolutionary divergence between vertebrates and 
invertebrates of these groups of genes, as seen in bioinformatics analyses, there are many factors 
showing its conservation functionally. This has been shown through the overexpression and 
knockdown of the gene in biometric, longevity and locomotor analyses. Further analyses should 
be carried out at the cellular and molecular levels such as microarray and PCR analyses 
especially due to the involvement of Paris in mitochondrial biogenesis and surveillance. As well, 
further research into the interaction of Paris with other genes such as spargel, parkin and PINK1. 
This current study has laid the foundation for more studies of the gene Paris.  
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